Invention Grant
- Patent Title: (N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide
-
Application No.: US15231411Application Date: 2016-08-08
-
Publication No.: US09809559B2Publication Date: 2017-11-07
- Inventor: Brandon H. Brown , Ernest A. Carra , Jeffrey N. Hemenway , Henry Morrison , Troy Reynolds , Bing Shi , Dimitrios Stefanidis , Fang Wang , Matthew Robert Warr , James Andrew Whitney , Yan Xin
- Applicant: Gilead Sciences, Inc.
- Applicant Address: US CA Foster City
- Assignee: GILEAD SCIENCES, INC.
- Current Assignee: GILEAD SCIENCES, INC.
- Current Assignee Address: US CA Foster City
- Main IPC: A61K31/535
- IPC: A61K31/535 ; A61K31/5377 ; C07D239/42 ; C07D265/30
Abstract:
The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use.
Public/Granted literature
- US20160347719A1 (N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BENZAMIDE Public/Granted day:2016-12-01
Information query
